Summary

Global IVF Market Trends & Summary

IVF Market is expected to reach US$ 49.12 billion 2033 from US$ 26.43 billion in 2024, with a CAGR of 7.13% from 2025 to 2033. Growing rates of infertility, improvements in reproductive technologies, increased awareness, postponed pregnancies, government assistance, expanding healthcare infrastructure, and growing desire for fertility preservation are some of the major factors propelling the IVF industry.

The report In Vitro Fertilization Market & Forecast covers by Procedure Type (Fresh non-donor, Frozen non-donor, Fresh Donor, Frozen Donor), Instrument (Disposable Devices, Culture Media, Equipment), Surgery (Embryo Culture, Cryopreservation, Sperm Processing, Ovum Processing, End Users (Fertility Clinics, Hospitals & Other Setting), Country and Company Analysis 2025-2033.


IVF Industry Overview

A mix of medication and surgery is utilized in in vitro fertilization (IVF), one of the most popular assisted reproductive technologies (ART). For an infertile couple, the IVF procedure aids in the development and implantation of the embryo. IVF is a method of fertilization that involves removing eggs, obtaining a sample of sperm, and then manually fusing the two in a lab. An estimated half a million infants are born each year as a result of the growing use of IVF and other assisted reproductive technologies. In vitro fertilization (IVF) treatment adoption is therefore expected to increase during the projection period due to the increased popularity of IVF and ICSI treatments.

Rising infertility rates, particularly as a result of postponed pregnancies and lifestyle modifications, are driving the IVF business. Significant contributions are also made by developments in reproductive technologies, such as enhanced success rates and genetic screening. The market is growing as a result of supporting government policies, increased access to healthcare services, and growing knowledge of fertility treatments. Further propelling the growth of the IVF market is the growing demand for fertility preservation, especially among women delaying childbirth.


Growth Drivers for the IVF Market

Growing Acceptance of Fertility Preservation Methods

The rise of fertility preservation methods, particularly egg freezing, is one of the factors driving market expansion. Customers are delaying childbearing for various personal, professional, or financial reasons, and freezing eggs and embryos is emerging as a preventive strategy to increase fertility. Furthermore, continuing developments in freezing technology are greatly assisting in the thawing of eggs and embryos. Notably, a study by Oxford Press found that the live birth rates following oocyte and embryo cryopreservation were 32% and 41%, respectively. Following tissue cryopreservation and transplanting for IVF, the spontaneous LBR is estimated to be 21% and 33%, respectively. This trend is also being accelerated by growing awareness of and access to fertility preservation services for cancer patients receiving treatments that may impact fertility, solidifying its position as a critical component of the changing market environment.


Increasing Genetic Screening Technology Integration

Preimplantation genetic testing (PGT) is the most prevalent genetic screening technology, and its integration into the industry has happened quickly. According to the IMARC Group analysis, the global market for genetic testing was valued at approximately USD 19.5 billion in 2024. Such genetic screening programs make it simpler to examine the embryo prior to implantation in order to determine whether the child may have genetic abnormalities because the likelihood of miscarriage decreases with increasing success rates. This is particularly effective for women undergoing IVF therapy who are deemed to be of advanced maternal age or for couples with a history of genetic illnesses. Growing knowledge of the part genetics plays in reproductive health and ongoing advancements in genetic testing technology, which make the procedures more accessible and accurate, are contributing factors to the increased demand for PGT. It is anticipated that genetic screening would significantly contribute to bettering outcomes worldwide and driving the industry as it continues to evolve.


Increasing Priority for Tailored Fertility Treatments

Fertility clinics are increasingly shifting toward individualized treatment regimens for each patient due to advancements in medical technology and a greater awareness of customers' reproductive health. In order to maximize success rates by reducing risks and enhancing embryo quality, personalized IVF techniques take into account the hormonal profile, genetic predispositions, and any underlying medical issues. Because it provides a more focused approach, this quick transition to personalized care is especially crucial for patients who may have experienced several unsuccessful IVF cycles. Personalized fertility treatments, which provide more efficient and patient-centered care in the in vitro fertilization market share, are anticipated to acquire more momentum as the need for customized medical solutions increases.


Challenges in the IVF Market

High Treatment Costs

A major obstacle facing the IVF market is the high cost of treatment, which prevents many people from accessing fertility treatments, particularly in low- to middle-income nations. Multiple cycles, prescription drugs, and consultations are among the costs, which frequently surpass patients' means. This problem is made worse by a lack of insurance coverage. Because of this, a large number of prospective patients postpone or decide not to undergo treatment, which restricts market expansion and keeps IVF technologies from being widely available.


Regulatory Hurdles

The IVF market is challenged by regulatory barriers because different nations have different laws and regulations. Due of the wide variations in restrictions on genetic testing, embryo research, and fertility preservation, clinics find it challenging to conduct business abroad. Strict laws restrict access to cutting-edge IVF technology in some areas, while uneven oversight in others may have an impact on the standard of care. Both patients and healthcare providers are left in the dark by these regulatory discrepancies, which also impede market growth.


IVF Market Overview by Regions

The growth of the IVF market varies by region. Because of their sophisticated healthcare systems, high levels of knowledge, and robust government support, North America and Europe are leaders. Growing rates of infertility and easier access to healthcare are fueling the Asia Pacific region's explosive expansion. Due to cultural factors and changing healthcare systems, demand is also rising throughout Latin America and the Middle East, but more slowly.


United States IVF Market

Due to reasons like rising infertility rates, improvements in reproductive technology, and increased knowledge of fertility treatments, the US IVF industry is expanding significantly. The rising number of same-sex couples and single women pursuing IVF to start kids is a significant motivator. About 1.2 million same-sex couples lived in the United States in 2021, with 500,000 of them being unmarried, according to statistics from the 2022 U.S. Census. This led to a rise in the demand for fertility treatments. In-vitro fertilization methods are also becoming more common. Approximately 368,502 cycles of assisted reproductive technology (ART) were carried out in 2021, a 19% increase over the year before. This development is a result of improved healthcare infrastructure, changing social norms surrounding family formation, and growing acceptance and accessibility of IVF therapies. The U.S. IVF industry is anticipated to keep growing in the upcoming years due to rising demand from a variety of demographics.


Germany IVF Market

Germany has one of the biggest IVF markets in Europe thanks to its sophisticated healthcare system and high level of fertility treatment awareness. The industry is expanding as a result of the nation's high medical standards, government assistance for reproductive healthcare, and rising acceptance of assisted reproductive technology. Additionally, ethical IVF methods are supported by legislation in Germany, such as those pertaining to genetic testing and embryo storage. The need for IVF procedures is being further fueled by rising incidence of infertility and postponed pregnancies.


India IVF Market

The adoption of cutting-edge assisted reproductive technologies, growing knowledge of fertility treatments, and rising infertility rates are all contributing to India's IVF market's explosive rise. India has emerged as a leading location for fertility treatments due to its excellent healthcare infrastructure and reasonably priced treatment alternatives. In May 2024, Birla Fertility and IVF acquired an 86% share in Kerala-based AMRC IVF, indicating market expansion and consolidation. This was one of the sector's major milestones.

Additionally, in January 2024, Thermo Fisher Scientific India named Srinath Venkatesh as Managing Director for India and South Asia, a move that is anticipated to enhance the company's role in utilizing cutting-edge laboratory technologies to revolutionize IVF operations. Additionally, Aveya Natural IVF & Fertility showed their dedication to preventive healthcare and growing reproductive health services by launching an HPV Vaccination Drive in January 2024 in partnership with Infinite Fertility. These programs demonstrate how innovation, smart alliances, and a growing emphasis on comprehensive fertility care have propelled the IVF market's explosive expansion in India.


Saudi Arabia IVF Market

Growing rates of infertility, greater knowledge of fertility therapies, and better healthcare infrastructure are driving the Saudi Arabian IVF market's rapid expansion. Market growth is facilitated by the government's funding of cutting-edge reproductive technology as well as cultural changes that accept assisted reproduction. The demand for IVF services is increased by Saudi Arabia's well-established healthcare system, top-notch fertility clinics, and an increase in medical tourism, positioning the nation as a regional leader in reproductive healthcare.


In Vitro Fertilization Market Segments

Procedure Type – Market breakup in 4 viewpoints:
1. Fresh non-donor
2. Frozen non-donor
3. Fresh Donor
4. Frozen Donor


Instrument – Market breakup in 3 viewpoints:
1. Disposable Devices
2. Culture Media
3. Equipment


Surgery – Market breakup in 4 viewpoints:
1. Embryo Culture Media
2. Cryopreservation Media
3. Sperm Processing Media
4. Ovum Processing Media


End Users – Market breakup in 2 viewpoints:
1. Fertility Clinics
2. Hospitals & Other Setting


Country – Market breakup of 25 Countries:
North America

1. United States
2. Canada

Europe

1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey

Asia Pacific

1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand

Latin America

1. Brazil
2. Mexico
3. Argentina

Middle East & Africa

1. South Africa
2. Saudi Arabia
3. UAE


All the Key players have been covered from 4 Viewpoints:
• Overview
• Key Persons
• Recent Development & Strategies
• Financial Insights


Company Analysis
1. FUJIFILM Holdings Corporation
2. Hamilton Thorne Ltd.
3. Vitrolife AB
4. Thermo Fisher Scientific, Inc.
5. Bayer AG
6. Merck & Co., Inc.
7. Boston IVF
8. Fortis Healthcare


Key Questions Answered in Report:
1. How big is the IVF industry?
The global IVF size was valued at US$ 26.43 billion in 2024 and is expected to reach US$ 49.12 billion in 2033.

2. What is the IVF industry growth rate?
The global IVF market is expected to expand at a compound annual growth rate (CAGR) of 7.13% from 2025 to 2033.

3. Who are the key players in IVF industry?
The top IVF companies are FUJIFILM Holdings Corporation, Hamilton Thorne Ltd., Vitrolife AB, Thermo Fisher Scientific, Inc., Bayer AG, Merck & Co., Inc., Boston IVF, Fortis Healthcare

4. What are the factors driving the IVF industry?
Key growth drivers of the IVF market include increasing infertility rates, advancements in reproductive technologies, rising awareness, delayed pregnancies, government support, growing healthcare infrastructure, and rising demand for fertility preservation.

5. Which Region held the largest market share in the IVF industry?
North America is expected to hold the largest market share in the industry.

6. What segments are covered in the IVF market report?
Procedure Type, Instrument, Surgery, End User and Countries segment are covered in this report.

ページTOPに戻る

Table of Contents

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global IVF Market


6. Market Share Analysis
6.1 Procedure Type
6.2 Instrument
6.3 Surgery
6.4 End Users
6.5 Country


7. Procedure Type
7.1 Fresh non-donor
7.2 Frozen non-donor
7.3 Fresh Donor
7.4 Frozen Donor


8. Instrument
8.1 Disposable Devices
8.2 Culture Media
8.3 Equipment


9. Surgery
9.1 Embryo Culture Media
9.2 Cryopreservation Media
9.3 Sperm Processing Media
9.4 Ovum Processing Media


10. End Users
10.1 Fertility Clinics
10.2 Hospitals & Other Setting


11. Country
11.1 North America

11.1.1 United States
11.1.2 Canada

11.2 Europe

11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey

11.3 Asia Pacific

11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 South Korea
11.3.6 Thailand
11.3.7 Malaysia
11.3.8 Indonesia
11.3.9 New Zealand

11.4 Latin America

11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina

11.5 Middle East & Africa

11.5.1 South Africa
11.5.2 Saudi Arabia
11.5.3 UAE


12. Porter’s Five Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat


14. Company Analysis
14.1 FUJIFILM Holdings Corporation
14.1.1 Overview
14.1.2 Key Persons
14.1.3 Recent Development & Strategies
14.1.4 Financial Insights

14.2 Hamilton Thorne Ltd.
14.2.1 Overview
14.2.2 Key Persons
14.2.3 Recent Development & Strategies
14.2.4 Financial Insights

14.3 Vitrolife AB
14.3.1 Overview
14.3.2 Key Persons
14.3.3 Recent Development & Strategies
14.3.4 Financial Insights

14.4 Thermo Fisher Scientific, Inc.
14.4.1 Overview
14.4.2 Key Persons
14.4.3 Recent Development & Strategies
14.4.4 Financial Insights

14.5 Bayer AG
14.5.1 Overview
14.5.2 Key Persons
14.5.3 Recent Development & Strategies
14.5.4 Financial Insights

14.6 Merck & Co., Inc.
14.6.1 Overview
14.6.2 Key Persons
14.6.3 Recent Development & Strategies
14.6.4 Financial Insights

14.7 Boston IVF
14.7.1 Overview
14.7.2 Key Persons
14.7.3 Recent Development & Strategies
14.7.4 Financial Insights

14.8 Fortis Healthcare
14.8.1 Overview
14.8.2 Key Persons
14.8.3 Recent Development & Strategies
14.8.4 Financial Insights